Consensus Grifols, S.A. Nasdaq

Equities

GRFS

US3984384087

Market Closed - Nasdaq 21:00:00 27/06/2024 BST 5-day change 1st Jan Change
6.3 USD -9.61% Intraday chart for Grifols, S.A. -9.74% -45.50%

Evolution of the average Target Price on Grifols, S.A.

Price target over the last 5 years

History of analyst recommendation changes

f8d99a042ee3ce55980d3cdf9.GKhNmBoPyWpd6wD6Bqmv74ac3zafBF2cZeKoZJzlhPM.YZ97oV91j1oym3LPTu2YoODxjkL9bD_KFJf7M8qU1cJp4RrdalyiDxzdaw~675e4ce75004088e9315ba2392bf252e
GRIFOLS : In line Q1 and on track deleveraging; worth a go Alphavalue
Grifols shares fall after new Gotham City Research report RE
GRIFOLS : Factoring in a more moderate earnings recovery; long-term view intact Alphavalue
Wall Street Set to Open Marginally Lower Friday Following Powell Speech, After Hitting Record Highs Thursday MT
Invest Securities Keeps Grifols at Buy, Trims PT MT
GRIFOLS : Market panic following yesterday’s conference call was unwarranted Alphavalue
GRIFOLS : adjusted target price at Invest Securities CF
GRIFOLS : Q4 in line; today’s adverse market reaction means a buying opportunity Alphavalue
GRIFOLS : Grifols accelerates its governance improvements post the short-seller’s allegations Alphavalue
GRIFOLS : Investors not impressed with the conference call; panic opens up attractive entry point Alphavalue
GRIFOLS : Dragged down by a short seller, but the management is ready to respond Alphavalue
GRIFOLS : Delivering on a much-needed deleveraging promise Alphavalue
GRIFOLS : Delivering on a much-needed deleveraging promise Alphavalue
JPMorgan Adjusts Grifols' Price Target to $10.50 From $10, Maintains Neutral Rating MT
GRIFOLS : Persistently-high interest rate impacts our near-term estimates; fundamentals remain intact Alphavalue
Invest Securities Trims Grifols PT, Maintains Buy Rating MT
GRIFOLS : Healthy Q3; deleveraging priorities remain on track Alphavalue
GRIFOLS : Good Q2; now all eyes on potential divestments Alphavalue
GRIFOLS : Spanish plasma giant making (gradual) progress Alphavalue
GRIFOLS : A potential divestment – a sigh of relief for investors Alphavalue
GRIFOLS : Upbeat Q1 a much-needed boost to investor confidence Alphavalue
GRIFOLS : Tightening its belt for deleveraging Alphavalue
Credit Suisse Reinstates Grifols With Neutral Rating, EUR10 Price Target; Sees Improving Plasma Collection Dynamics Offset by High Debt MT
European Equities Follow US Markets Lower on Interest Rate Concerns MT
Roche’s Alzheimer’s failure has sector-wide implications Alphavalue
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
7.97 EUR
Average target price
17.41 EUR
Spread / Average Target
+118.40%
High Price Target
25 EUR
Spread / Highest target
+213.68%
Low Price Target
9 EUR
Spread / Lowest Target
+12.92%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Grifols, S.A.

alphavalue Abhishek Raval
Invest Securities
JPMorgan Chase
Credit Suisse
Morgan Stanley
Citigroup
Deutsche Bank Securities
HSBC
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings